Page last updated: 2024-11-02

phenazopyridine and Hospital-Acquired Condition

phenazopyridine has been researched along with Hospital-Acquired Condition in 1 studies

Phenazopyridine: A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
phenazopyridine : A diaminopyridine that is 2,6-diaminopyridine substituted at position 3 by a phenylazo group. A local anesthetic that has topical analgesic effect on mucosa lining of the urinary tract. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, SA1
Chaudhry, Z1
Oliver, JL1
Kreydin, EI1
Nguyen, MT1
Mills, SA1
Ackerman, AL1
Kim, JH1
Tarnay, CM1
Raz, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Use of Dye-less Cystoscopy in Assessing Urinary Tract Integrity During Hysterectomy[NCT05190939]276 participants (Actual)Interventional2018-07-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for phenazopyridine and Hospital-Acquired Condition

ArticleYear
Comparison of Times to Ureteral Efflux after Administration of Sodium Fluorescein and Phenazopyridine.
    The Journal of urology, 2017, Volume: 197, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Cystoscopy; Female; Fluorescein; Fluorescent Dyes; Humans; Iatrogeni

2017